FDA Approves Drug Patch for Schizophrenia

A new transdermal patch used for the treatment of schizophrenia developed by Noven Pharmaceuticals Inc., has been approved by the U.S. Food and Drug Administration, according to the Tullahoman Tennessee News. The once-daily transdermal patch provides 24 hours of sustained concentrations of an antipsychotic drug called asenapine, used for the treatment for schizophrenia. It's estimated that 54 million Americans are affected with a mental illness in a given year, including schizophrenia,...

Read the Full Article for Free!

You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy

Subscribe for FREE to the #1 Natural Health Newsletter or Login for Instant Access

Unlock censored health information that Google doesn't want you to read

Keep your privacy secure — we are one of the few websites that have banned all Google and Facebook scripts to help stop their surveillance capitalism

Get access to all of Dr. Mercola's health articles, E-books and special reports